Table 2
Clinical and haematological characteristics of the patients
| CRVO + HRVO No (%) |
BRVO No (%) |
Control No (%) |
|
|---|---|---|---|
| ↑ triglycerides | 2 (9) | 6 (18.8) | 4 (21) |
| ↑ cholesterol | 8 (36.3) | 22 (68.8) | 5 (26.3) |
| ↓ protein C activity | 1 (4.5) | 1 (3.1) | 0 |
| APCR | 0 | 1 (3.1) | 0 |
| ↓ free protein S | 0 | 1 (3.1) | 0 |
| ↓ atIII activity | 1 (4.5) | 0 | 1 (5.3) |
| WBC (×106/l) (mean) | 3800 -10600 (6970) | 4500–14100 (6800) | 4700–10680 (7150) |
| Haemoglobin (g/dl) (mean) | 12.5–16.6 (14.47) | 12.1–15.5 (13.87) | 10.8–17.5 (14.48) |
| Thrombocytes (×109/l) (mean) | 156–317 (205) | 189–499 (222) | 200–329 (207) |
| Factor VIIa (mU/ml) (median) | 16.1–1434 (74) | 28–1309(89.8) | 9.9–99.6 (41.6) |
| Fibrinogen (mg/dl) (mean) | 253–493 (363.5) | 234–530 (349.3) | 270–700 (358.2) |
-
CRVO = central retinal vein occlusion; BRVO = branch retinal vein occlusion; HRVO = hemiretinal vein occlusion; APCR = activated protein C resistance; atIII = antithrombin III; WBC = white blood cell.
-
↵Statistically significant difference from controls.
